Diana Zatreanu, Postdoctoral research fellow
The best thing about working at the ICR is the close-knit family feeling, which improves collaborations and scientific discoveries.
Thousands of blood cancer patients could benefit from new drug combination
Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer.
ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS money
A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending drug abiraterone.